Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Uncontrolled Phase 4 Study to Assess the Safety and Immunogenicity of the Japanese Encephalitis (JE) Vaccine Ixiaro® (IC51) in an Elderly Population

NCT01158599 is registered in ClinicalTrials.gov with Valneva Austria GmbH as lead sponsor.

NCT NCT01158599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01158599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Uncontrolled Phase 4 Study to Assess the Safety and Immunogenicity of the Japanese Encephalitis (JE) Vaccine Ixiaro® (IC51) in an Elderly Population
Lead sponsor
Valneva Austria GmbH
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2010
Completion date
October 31, 2011
Enrollment
200 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

japanese encephalitis